Royal Bank of Canada
IMA

Royal Bank of Canada’s ImageneBio Inc IMA Stock Holding History

Royal Bank of Canada’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Hold
1,000
– – ﹤0.01% 6420
2025
Q4 		$7K Buy
+1,000
New +$7.42K ﹤0.01% 6584
2025
Q3 		– Sell
-1,333
Closed -$21K – 7298
2025
Q2 		$21K Buy
+1,333
New +$19.6K ﹤0.01% 6242
2024
Q2 		– Sell
-59
Closed -$1K – 7268
2024
Q1 		$1K Sell
59
-850
-94% -$15.5K ﹤0.01% 6802
2023
Q4 		$21K Buy
909
+552
+155% +$18K ﹤0.01% 6291
2023
Q3 		$18K Buy
357
+137
+62% +$8.25K ﹤0.01% 6213
2023
Q2 		$18K Buy
220
+198
+900% +$14.2K ﹤0.01% 6264
2023
Q1 		$1K Buy
+22
New +$1.01K ﹤0.01% 6897
2022
Q4 		– Sell
-19
Closed -$1K – 7444
2022
Q3 		$1K Buy
19
+3
+19% +$173 ﹤0.01% 7201
2022
Q2 		$1K Sell
16
-126
-89% -$6.95K ﹤0.01% 7136
2022
Q1 		$10K Sell
142
-337
-70% -$35.8K ﹤0.01% 6942
2021
Q4 		$72K Buy
479
+354
+283% +$57.4K ﹤0.01% 6157
2021
Q3 		$19K Buy
125
+73
+140% +$10.6K ﹤0.01% 6725
2021
Q2 		$9K Buy
+52
New +$11.5K ﹤0.01% 6912

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada's IMA Position: Q1 2026 in Review

Royal Bank of Canada held its ImageneBio Inc (IMA) position steady in Q1 2026 at 1,000 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6420.

Royal Bank of Canada first reported a position in IMA in Q2 2021 and has held it in 14 quarters since. The position peaked at $72K in Q4 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Royal Bank of Canada held 1,000 shares of ImageneBio Inc worth $5K as of Q1 2026.
  • Royal Bank of Canada left its ImageneBio Inc share count unchanged in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6420 holding.
  • Royal Bank of Canada first reported a position in ImageneBio Inc in Q2 2021 and has held it in 14 quarters since.
  • Royal Bank of Canada's ImageneBio Inc position peaked at $72K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.